Related Experiment Video
Updated: Dec 26, 2025

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
Published on: November 1, 2024
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
Paolo Petazzi1, Raul Torres-Ruiz2, Antonella Fidanza3
1Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
Abstract:
Human pluripotent stem cells (hPSCs) and mesenchymal stromal/stem cells (hMSCs) are clinically relevant sources for cellular therapies and for modeling human development and disease. Many stem cell-based applications rely on the ability to activate several endogenous genes simultaneously to modify cell fate. However, genetic intervention of these cells remains challenging. Several catalytically dead Cas9 (dCas9) proteins fused to distinct activation domains can modulate gene expression when directed to their regulatory regions by a specific single-guide RNA (sgRNA). In this study, we have compared the ability of the first-generation dCas9-VP64 activator and the second-generation systems, dCas9-SAM and dCas9-SunTag, to induce gene expression in hPSCs and hMSCs. Several stem cell lines were tested for single and multiplexed gene activation. When the activation of several genes was compared, all three systems induced specific and potent gene expression in both single and multiplexed settings, but the dCas9-SAM and dCas9-SunTag systems resulted in the highest and most consistent level of gene expression. Simultaneous targeting of the same gene with multiple sgRNAs did not result in additive levels of gene expression in hPSCs nor hMSCs. We demonstrate the robustness and specificity of second-generation dCas9 activators as tools to simultaneously activate several endogenous genes in clinically relevant human stem cells.
Insights
Second-generation CRISPR activators, dCas9-SAM and dCas9-SunTag, effectively activate multiple genes simultaneously in human stem cells. These advanced systems offer robust and specific gene expression for cellular therapies and disease modeling.
Area of Science:
- * Molecular Biology
- * Gene Regulation
- * Stem Cell Biology
Background:
- * Human pluripotent stem cells (hPSCs) and mesenchymal stromal/stem cells (hMSCs) are crucial for cellular therapies and disease modeling.
- * Modifying cell fate requires simultaneous activation of multiple endogenous genes, which is challenging in these cells.
- * Catalytically dead Cas9 (dCas9) fused to activation domains, guided by sgRNAs, can modulate gene expression.
Purpose of the Study:
- * To compare the efficacy of first-generation (dCas9-VP64) and second-generation (dCas9-SAM, dCas9-SunTag) dCas9 activators for gene induction in hPSCs and hMSCs.
- * To evaluate single and multiplexed gene activation capabilities of these systems.
- * To assess the robustness and specificity of dCas9 activators in clinically relevant human stem cells.
Main Methods:
- * Testing of dCas9-VP64, dCas9-SAM, and dCas9-SunTag systems for gene activation in various hPSC and hMSC lines.
- * Application of single-guide RNA (sgRNA) to direct dCas9 activators to target gene regulatory regions.
- * Comparison of gene expression levels following single and multiplexed gene activation strategies.
Main Results:
- * All three dCas9 activator systems induced specific and potent gene expression in both single and multiplexed settings.
- * Second-generation systems (dCas9-SAM and dCas9-SunTag) demonstrated superior and more consistent gene expression levels compared to dCas9-VP64.
- * Simultaneous targeting of the same gene with multiple sgRNAs did not yield additive gene expression increases in either hPSCs or hMSCs.
Conclusions:
- * Second-generation dCas9 activators (dCas9-SAM and dCas9-SunTag) are highly effective tools for simultaneous gene activation in human stem cells.
- * These systems offer robust and specific gene expression modulation, crucial for advancing cellular therapies and research.
- * The study validates the utility of dCas9-SAM and dCas9-SunTag for genetic manipulation in clinically relevant stem cell applications.
More Related Videos
09:03Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
11:36Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus
Published on: November 20, 2016
Related Concept Videos
Caspases
Induced Pluripotent Stem Cells
Somatic...